Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pulmonary ventilation function refers to the physiological process by which air is moved in and out of the lungs—enabling oxygen delivery to the blood and the removal of carbon dioxide from the body. This function relies on pressure changes within the respiratory system, generated by contraction and relaxation of respiratory muscles such as the diaphragm and the intercostal muscles. Although impaired pulmonary ventilation is central to many diseases (e.g. asthma, COPD, restrictive lung disease), "pulmonary ventilation function" describes a measure of physiology, not a molecular target for direct pharmacological intervention[1][2][3][4][6][7]. There is something incorrect about this target: it is not a molecule, gene, receptor, transporter, or enzyme, and thus not a canonical therapeutic or diagnostic "target." It is a physiological process measured in clinical settings, usually as an endpoint or biomarker. Drugs and interventions that improve pulmonary ventilation typically do so by targeting molecular structures elsewhere (e.g., β2-adrenergic receptors, muscarinic receptors, ion channels)[4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pulmonary ventilation function.